IRIS Institutional Research Information System - OPENBS Open Archive UniBS

METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 108.988
AS - Asia 59.420
EU - Europa 47.979
SA - Sud America 12.932
Continente sconosciuto - Info sul continente non disponibili 2.083
AF - Africa 1.372
OC - Oceania 139
AN - Antartide 2
Totale 232.915
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 106.128
SG - Singapore 19.541
CN - Cina 19.209
UA - Ucraina 10.951
BR - Brasile 10.767
IT - Italia 8.530
HK - Hong Kong 7.860
RU - Federazione Russa 5.414
DE - Germania 5.234
PL - Polonia 3.696
FR - Francia 3.641
VN - Vietnam 3.462
FI - Finlandia 3.059
GB - Regno Unito 2.886
TR - Turchia 2.365
IN - India 2.148
IE - Irlanda 1.978
BD - Bangladesh 1.743
CA - Canada 1.359
AR - Argentina 789
SE - Svezia 716
MX - Messico 579
IQ - Iraq 492
NL - Olanda 397
ID - Indonesia 393
EC - Ecuador 364
ZA - Sudafrica 361
JP - Giappone 301
CO - Colombia 277
SA - Arabia Saudita 273
AT - Austria 258
PK - Pakistan 255
ES - Italia 243
VE - Venezuela 209
MA - Marocco 177
JM - Giamaica 167
NG - Nigeria 166
KE - Kenya 159
UZ - Uzbekistan 155
PY - Paraguay 153
CR - Costa Rica 146
CL - Cile 141
CZ - Repubblica Ceca 136
BE - Belgio 134
AU - Australia 126
QA - Qatar 120
EG - Egitto 106
TN - Tunisia 103
PH - Filippine 101
HN - Honduras 100
EE - Estonia 97
TT - Trinidad e Tobago 96
AE - Emirati Arabi Uniti 95
PE - Perù 92
JO - Giordania 87
MY - Malesia 87
NP - Nepal 87
MU - Mauritius 86
UY - Uruguay 85
IL - Israele 79
EU - Europa 76
NI - Nicaragua 70
RO - Romania 66
LT - Lituania 62
KR - Corea 55
AL - Albania 54
IR - Iran 54
AZ - Azerbaigian 53
CH - Svizzera 53
DZ - Algeria 53
PA - Panama 51
GT - Guatemala 50
KZ - Kazakistan 50
TH - Thailandia 49
ET - Etiopia 47
PR - Porto Rico 44
SV - El Salvador 44
DO - Repubblica Dominicana 43
OM - Oman 43
BO - Bolivia 41
MD - Moldavia 41
LB - Libano 37
TW - Taiwan 36
PT - Portogallo 34
BB - Barbados 33
BG - Bulgaria 33
NO - Norvegia 33
GR - Grecia 31
HU - Ungheria 30
PS - Palestinian Territory 30
SC - Seychelles 29
SN - Senegal 28
LV - Lettonia 25
DK - Danimarca 24
BH - Bahrain 23
RS - Serbia 23
KG - Kirghizistan 22
SK - Slovacchia (Repubblica Slovacca) 20
SY - Repubblica araba siriana 18
HR - Croazia 16
Totale 230.583
Salva come PNG Salva come JPEG
Città #
Ashburn 10.536
Singapore 10.057
Fairfield 8.126
Jacksonville 8.023
Hong Kong 7.817
Woodbridge 6.027
San Jose 5.888
Houston 4.260
Chandler 4.080
Moscow 4.056
Council Bluffs 3.896
Beijing 3.787
The Dalles 3.777
Warsaw 3.620
Cambridge 3.596
Princeton 3.527
Wilmington 3.442
Ann Arbor 3.252
Seattle 3.143
Nanjing 2.769
New York 2.496
Dublin 1.951
Lauterbourg 1.885
Istanbul 1.845
Los Angeles 1.754
Columbus 1.702
Helsinki 1.492
Ho Chi Minh City 1.228
São Paulo 1.060
Milan 1.041
Nanchang 1.039
Buffalo 1.017
Des Moines 828
Dallas 801
Santa Clara 734
Shenyang 684
Hanoi 673
Hebei 661
Redondo Beach 626
Changsha 615
Tianjin 544
Chicago 539
Munich 523
San Diego 523
Rome 493
Brescia 463
Jiaxing 458
Phoenix 455
Shanghai 432
San Francisco 425
Jinan 411
Orem 398
London 379
Dearborn 378
North Bergen 372
Toronto 369
Rio de Janeiro 344
Boardman 342
Hangzhou 327
Kunming 322
Atlanta 303
Frankfurt am Main 302
Brooklyn 269
Tokyo 259
Nuremberg 257
Verona 250
Kocaeli 247
Chennai 243
Montreal 241
Belo Horizonte 236
Guangzhou 222
Romola 221
Mexico City 209
Brasília 198
Zhengzhou 197
Denver 178
Boston 175
Lancaster 175
Turku 171
Naples 168
Charlotte 162
Johannesburg 160
Curitiba 158
Lappeenranta 148
Pune 148
Dhaka 147
Abuja 146
Porto Alegre 141
Manchester 140
Ningbo 140
Tashkent 140
Washington 135
Lanzhou 134
Baghdad 133
Da Nang 132
Haiphong 132
Nairobi 131
Salvador 127
Quito 123
Stockholm 122
Totale 143.628
Salva come PNG Salva come JPEG
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis 3.395
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 745
Effect of nesiritide in patients with acute decompensated heart failure. 564
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 518
American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 441
Inodilatatori: perché e quali. 418
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 410
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial 404
Farmaci inotropi non digitalici. 401
La cardiomioplastica dinamica come trattamento della cardiomiopatia dilatativa ingravescente. 391
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 375
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 374
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine 366
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 355
Can we improve the treatment of congestion in heart failure? 333
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 316
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 313
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. 307
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure 306
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. 298
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 298
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 295
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure 286
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the ESC 282
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 281
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. 278
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 276
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 275
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 273
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 271
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study 271
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 266
Old and new intravenous inotropic agents in the treatment of advanced heart failure 264
[West Nile virus and myocarditis, a rare event: case report] 252
Postdischarge assessment after a heart failure hospitalization: the next step forward. 248
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. 247
May 2020 at a glance: ischaemic heart failure and sex-related differences 246
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. 242
Sindromi coronariche acute: ruolo dell’infezione cronica da Helicobacter Pylori e Citomegalovirus. 241
Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. 241
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 238
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study 237
Highlights of the 2009 scientific sessions of the European Society of Cardiology. 234
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: A randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF) 229
Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC 226
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 226
Effects of serelaxin in patients with acute heart failure 226
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Societyof Cardiology 223
Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure an Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine ReceptorAntagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) 222
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. 221
Characteristics and mid-term follow-up of a single-center population affected by Tako-Tsubo cardiomyopathy 221
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 217
Task Force sullo Scompenso Cardiaco Acuto della Societa Europea di Cardiologia. Versione italiana a cura di A Gavazzi, M Metra. Riassunto esecutivo delle linee guida sulla diagnosi e trattamento dello scompenso cardiaco acuto. 216
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 216
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. 210
Global epidemiology of heart failure 207
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 207
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 206
Clinical trials update from the World Congress of Cardiology 2006. 205
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 202
1Beta-2 adrenergic receptors gene polymorphisms influence the effects of carvedilol in the patients with heart failure. 201
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 201
Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction 201
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 200
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 200
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 200
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 199
2024 update in heart failure 197
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 197
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 195
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 194
A rationale for the use of BETA-blockers as standard treatment for heart failure 193
A case of iatrogenic severe mitral regurgitation 192
Amino acids and derivatives, a new treatment of chronic heart failure? 192
Can we prevent or treat renal dysfunction in acute heart failure? 191
ESC Committe for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. 191
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 191
A drastic complex atheromatous aorta. A case report. 190
Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results 190
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 188
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 187
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 187
Effectiveness of MitraClip therapy in patients with refractory heart failure 187
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 186
A randomized double blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant hypertension. Ca+ Nicardipine. Selected reports from the worldwide literature. 183
Neurohormonal activation in acute heart failure: results from VERITAS 183
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 182
A case of iatrogen severe mitral regurgitation 182
Agents with vasodilator properties in acute heart failure: how to design successful trials 182
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 181
Beta- adrenergic receptors polymorphisms and response to CRT 181
An unusual case of myocardial infarction 180
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 180
Heart failure with preserved ejection fraction: is the role of arterial stiffness established? 178
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 176
Low Lymphocyte Ratio as a Novel Prognostic Factor in Acute HeartFailure: Results from the Pre-RELAX-AHF Study. 176
insights into cardiac subclinical alterations after pre-eclampsia: a 2d strain study 176
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 175
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 175
Effect of High dose of atorvastatin versus moderate dose on endothelial function and inflammatory biomarkers in patients with STEMI 175
Totale 28.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.211.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.211.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.557 0 0 0 766 247 619 378 980 645 1.314 1.113 2.495
2022/202312.147 1.996 251 132 993 1.078 3.560 47 1.193 1.744 107 505 541
2023/202412.841 751 279 741 836 523 1.814 459 472 3.491 339 741 2.395
2024/202533.621 983 971 811 3.716 3.829 2.483 2.749 1.474 2.819 2.919 6.439 4.428
2025/202663.796 5.952 9.469 5.063 9.576 4.786 3.825 8.780 2.940 4.020 5.453 2.486 1.446
2026/202722.743 3.383 3.308 6.584 9.468 0 0 0 0 0 0 0 0
Totale 232.915